Last update 01 Nov 2024

JNJ-47910382

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
Hepatitis C virus NS 5 protein
Mechanism
Hepatitis C virus NS 5 protein inhibitors
Therapeutic Areas
Infectious DiseasesDigestive System Disorders
Active Indication-
Inactive Indication
Chronic hepatitis C genotype 1Hepatitis C
Originator Organization
Janssen Global Services LLCJanssen Global Services LLC
Active Organization-
Inactive Organization
Johnson & Johnson (Ireland) Ltd.
Drug Highest PhaseDiscontinuedPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

4
Clinical Trials associated with JNJ-47910382
NCT01651767 / TerminatedPhase 1
A Phase Ib, Randomized, Double-Blind, Placebo-Controlled Trial in Caucasian Genotype 1 Chronic HCV-Infected Subjects to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Repeated Doses of JNJ-47910382 Given in Different Doses and Dose Regimens
NCT01662661 / CompletedPhase 1
A Phase I, Open-Label, Randomized, 2-way Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of a Single Oral Dose of JNJ-47910382 Formulated as a Tablet and as a Suspension
NCT01586325 / TerminatedPhase 1
A Phase Ib, Randomized, Double-Blind, Placebo-Controlled Trial in Asian Genotype 1 Chronic HCV-Infected Subjects to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Repeated Doses of JNJ-47910382 Given in Different Doses and Dose Regimens
100 Clinical Results associated with JNJ-47910382
Login to view more data
100 Translational Medicine associated with JNJ-47910382
Login to view more data
100 Patents (Medical) associated with JNJ-47910382
Login to view more data
100 Deals associated with JNJ-47910382
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Chronic hepatitis C genotype 1Preclinical
TW
Johnson & Johnson (Ireland) Ltd.
25 May 2012
Hepatitis CDiscovery
DE
Johnson & Johnson (Ireland) Ltd.
01 Nov 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free